ArticleCancer research2025

Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer.

Shripad V Bhagwat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.